Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 8.19086 | 94 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 8.38994 | 95 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 8.18154 | 94 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 8.92813 | 96 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 8.27724 | 94 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 7.73619 | 93 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 8.07508 | 95 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 8.13959 | 94 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 8.37847 | 95 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 8.9223 | 96 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 8.90938 | 96 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 8.8056 | 96 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 9.27056 | 97 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 8.80422 | 96 |